Dx dialogues: the challenges of treating tardive dyskinesia the "old-fashioned way"
Dx dialogues: why early intervention is critical in managing tardive dyskinesia
Dx dialogues: pharmacologic advances for the treatment and management of schizophrenia
Dx dialogues: novel approaches in development for the treatment of AD
Treating tardive dyskinesia
5 tips for finding the best treatment for tardive dyskinesia
Dx dialogues: considerations when deciding whether to initiate pharmacologic interventions for patients with AD
Dx dialogues: stigma surrounding LAI use for schizophrenia and the importance of patient education
Dx dialogues: identifying patients who might benefit from an LAI for schizophrenia
5 complications of living with tardive dyskinesia
Too much screen time can harm sleep, mood, and much more.
ROS1 is a biomarker found in a small number of lung cancers, and it can change how the disease is treated.
Targeted therapy is the main treatment for ROS1-positive lung cancer, and other options are available if a drug stops working.
Find out why cynical people may be more likely to develop dementia.
Strategies for keeping medications and dosing schedules organized when treating congenital adrenal hyperplasia.